Archive: 17/06/2015

Discovery may lead to targeted melanoma therapies

Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a study led by researchers at Icahn School of Medicine at Mount Sinai and published ...

Researchers identify new genetic immune disorder

Researchers funded by the National Institutes of Health (NIH) have identified a new immune disorder—DOCK2 deficiency—named after the mutated gene responsible for the disease. An international team of collaborators studied ...

page 1 from 10